News

How do agarose resins contribute to genome stability to prevent genetic diseases?

The E3 ubiquitin ligase RNF2 protects polymerase ι from destabilization and represents a potential therapeutic target for diseases associated with DNA instability.

Read more

Optimization of the drug discovery process using agarose resins

Drug discovery process is the method trough which potential new therapeutic entities are identified using different scientific techniques

Read more

See you at MEDICA 2024: Accelerating diagnostic innovation

Agarose Bead Technologies will be exhibiting in Hall 3, Booth D95 from November 11-14 in Düsseldorf, Germany.

Read more

Next stop: The industry's top trade shows

Agarose Bead Technologies (ABT) is excited to announce our participation in several important trade fairs this October.

Read more

Agarose Bead Technologies expands facility to meet rising global demand for novel therapies market

Agarose Bead Technologies has enhanced its Burgos facility by boosting its agarose resin production to 100,000 liters annually to position itself as a powerhouse in the novel therapies market.

Read more

See you at Bioprocess International Conference and Exhibition 2024

ABT will be exhibiting at one of the most prestigious events in the bioprocessing industry, the Bioprocess International Conference. This prestigious event will be held...

Read more

The significance of protein purification in the fight against cancer

Discover how ABT's Nickel NTA Agarose Resin is paving the way for new immunotherapy breakthroughs that could transform treatments for immune-related diseases...

Read more

We’re celebrating: Our brand-NEW Website is live!

Our new website is more than just a visual upgrade. It represents our commitment to providing the best possible resources and information to our clients and partners in the bioprocessing and biopharmaceutical industries...

Read more

Unveiling the role of TAOK3 and SHP-1 in T cell activation: Protein isolation and purification

Modulation of SHP-1 abundance by TAOK3 serves as a rheostat for TCR signaling and determines the activation threshold of T lymphocytes.

Read more

"With this certification, ABT consolidates its position as a technological and innovative company, reaffirming its commitment to the development of high-performance agarose resins for the biopharmaceutical and bioprocessing industries."

ABT has been awarded the "Innovative SME" seal by the Spanish Ministry of Science, Innovation and Universities, a recognition that rewards the investments made by SMEs in R&D+i. This seal confirms the company's commitment to research, custom development and innovation in the field of bioprocessing.

Agarose Bead Technologies (ABT) is a leading European manufacturer of agarose resins supporting the biopharmaceutical industry.

Agarose resins are manufactured under a rigorous Quality Management System (QMS) to meet the requirements of the bioprocessing industry.

These resins are used in a variety of process development and commercial scale cGMP chromatographic purification applications.

CUSTOM RESINS FOR EFFICIENT BIOPROCESSING

We manufacture our custom products to meet specific customer requirements, adhere to industry standards, and facilitate large-scale production. With two ISO 9001:2015 certified manufacturing facilities, we are well equipped to produce and deliver significant volumes for GMP manufacturing.

These strategically located sites utilize state-of-the-art technology to create customized resins that meet the highest GMP standards, ensuring efficient large-scale production.

Our expanding global presence, with facilities in both Europe and the USA, enables us to provide innovative chromatography resins that meet the changing needs of the biopharmaceutical sector.

GUARANTEE OF THE 'INNOVATIVE SME' LABEL

Obtaining this label indicates that our company is committed to improving and developing products or services through innovation. It also demonstrates a commitment to continuous improvement and sustainable development.

ABT has the skills and resources to carry out high quality technological projects, having passed an evaluation that verifies its R+D+i activities and meets the criteria established by the Spanish Ministry of Science and Innovation.

With this certification, ABT consolidates its position as a technological and innovative company, reaffirming its commitment to the development of high-performance agarose resins for the biopharmaceutical and bioprocessing industries.

Agarose Bead Technologies (ABT) is a leading European manufacturer of agarose resins supporting the Biopharmaceutical and Bioprocessing industry. Agarose resins are manufactured under a rigorous quality management system (QMS) needed to meet the requirements of the bioprocessing industry.

Cookie consent
Product added to wishlist